Kyorin Pharmaceutical Co (Kyorin Pharmaceutical Co) Inventories, Raw Materials & Components : $134.6 Mil (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Kyorin Pharmaceutical Co Inventories, Raw Materials & Components?

Kyorin Pharmaceutical Co's inventories, raw materials & components for the quarter that ended in Dec. 2023 was $134.6 Mil.

Kyorin Pharmaceutical Co's quarterly raw materials declined from Jun. 2023 ($146.1 Mil) to Sep. 2023 ($128.2 Mil) but then increased from Sep. 2023 ($128.2 Mil) to Dec. 2023 ($134.6 Mil).

Kyorin Pharmaceutical Co's annual raw materials increased from Mar. 2022 ($130.2 Mil) to Mar. 2023 ($148.7 Mil) but then declined from Mar. 2023 ($148.7 Mil) to Mar. 2024 ($132.3 Mil).

Kyorin Pharmaceutical Co Inventories, Raw Materials & Components Historical Data

The historical data trend for Kyorin Pharmaceutical Co's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyorin Pharmaceutical Co Inventories, Raw Materials & Components Chart

Kyorin Pharmaceutical Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Inventories, Raw Materials & Components

Get a 7-Day Free Trial

85.25

107.91

130.19

148.67

132.27

Kyorin Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Inventories, Raw Materials & Components	Get a 7-Day Free Trial															148.67	146.12	128.18	134.64	132.27

Kyorin Pharmaceutical Co Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

Kyorin Pharmaceutical Co (Kyorin Pharmaceutical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kyorin Pharmaceutical Co Ltd (OTCPK:KYRNF) » Definitions » Inventories, Raw Materials & Components

Comparable Companies

Traded in Other Exchanges

4569:Japan

Address

6, Kanda Surugadai 4-chome, Chiyoda-ku, Tokyo, JPN, 101-8311

Website

https://www.kyorin-pharm.co.jp

Kyorin Pharmaceutical Co Ltd is engaged in manufacturing and sale of pharmaceutical products. The company manages its business in two reportable segments namely Pharmaceutical Business and the Consumer Healthcare (Skincare) Business. The Pharmaceutical business focuses on producing and selling ethical drugs, generic drugs and over-the-counter drugs. The Consumer Healthcare (Skincare) Business mainly sells and purchases skincare products. The company's products include Kipres, for treating bronchial asthma and allergic rhinitis; Mucodyne, a mucoregulant; Pentasa, for treating ulcerative colitis and Crohn's disease; and Uritos, for treating overactive bladder. Majority of the company's revenue comes from domestic sales.

Kyorin Pharmaceutical Co (Kyorin Pharmaceutical Co) Headlines

No Headlines